Mission statement · Company scope
“Our mission is to bring to market therapies that address high unmet medical needs of patients with genetic mitochondrial diseases.”
In use2023 – now1 sighting
First seenMar 2023Added
Last seenMar 2023Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Product offering (primary) · Problem–solution
- Leads with
- Product
- Best for
- Climate & health
- Formula
- We make [product] for [who]
- Tone
- Plain
- Length
- 20 words · reading grade 13.5
- Review status
- unreviewed · classifier rules-v0
- Quality score
- 0.74
- Record
- st_9c3062c6e1acdf8f
- Classification confidence
- 0.67
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2023-03-27 · sec_sentence · 10-K · accession 0000950170-23-009978
View filing ↗0 to compareCompare